Abonnez-vous à notre lettre d'information pour rester informé
Cliquez ici
  • BLS
  • Spotlight

Safety guide: chemical pharmaceutical industry

BLS Safety Guide: chemical-pharmaceutical industry


A guide written by Dr. Antonio Moffa, Dr. Claudia Beccaria and Lucrezia Giorgi of the Unit of Integrated Therapies in Otolaryngology at the University Polyclinic Campus Bio-Medical Foundation in Rome.

 

The manufacture of pharmaceutical products involves the use of numerous chemicals, obtained by fermentation, organic or biological synthesis, which can sometimes be used in very high concentrations and risk endangering the health or safety of operators.

 

 

The handling of chemical or biological substances used in drugs and reagents involves acute and chronic risks. The toxic effects, such as mutagenesis and neurotoxicity, are often irreversible and may persist over time. The most commonly used products include solvents, corrosive acids and caustic bases. It is essential to manage these risks to ensure the safety of operators and the public.

Granulating, mixing and wet coating operations can expose operators to high solvent vapours. During other steps such as distribution, drying and mixing, airborne particles may increase exposure. Thehandling and storage of these products pose risks of exposure through inhalation, ingestion or direct contact during plant breakdowns. These risks must be carefully managed to prevent harmful exposures and related diseases. Below are the risks related to the various work steps of toxic products and associated diseases. (see table)

 

 

Toxicity risks depend on the physical and chemical properties of the products and the routes of entry into the body. Workers in pharmaceutical industries may be exposed to chemicals through inhalation, skin contact, ingestion and eye projection. Common occupational diseases in the industry include osteomuscular, respiratory, ear problems, tumours and other diseases. Exposures to dust, gaseous compounds and solvent vapours can cause allergic reactions, respiratory disorders and cancers. The substances most frequently implicated as causes of occupational diseases include asbestos, hydrocarbon derivatives and other specific chemicals.

 

 

In pharmaceutical industries, risk prevention is based on a number of collective and individual measures. Collective measures include adequate infrastructure such as well-designed rooms, safe work plans and effective ventilation devices to capture pollutants. Automation of operations through remote-controlled and controlled systems reduces the risk of operator exposure. In addition, hygienic equipment such as safety showers and eye wash stations are essential, along with hygienic practices such as hand washing.

 

In order to protect operators from chemical hazards arising from pharmaceuticals, excipients, solvents and disinfectants, the use of personal protective equipment is required. These include:

- Hand protectors, protecting against chemicals, heat, frost and potential allergens.
- Eye and face protectors, protecting against splashes, drops, dusts and irritating gases.
- Body protectors, especially in case of exposure to corrosive substances.
- Respiratory devices, protecting against the harmful effects of gases, vapours, dusts, fibres, fumes and mists.

Furthermore, it is essential that operators receive training and detailed information on the risks associated with the products and materials used, so that they can adopt safe behaviour while working.

 

Recommended products:

 

 

 

Stay informed
Stay safe.

 

Articles Liés

novembre 10, 2022 Donning Instructions | BLS 500 series

Sai indossare correttamente un DPI? Indossare un DPI nel modo corretto è fondamentale per trarne massima efficacia e migliori performance di prodotto.   Lo scopo della protezione respiratoria individuale è proteggere chi la indossa da sostanze tossiche o patogene diffuse per via aerea. Il suo utilizzo, quindi, dovrebbe essere preceduto da una formazione appropriata sulle […]

Link
juillet 22, 2022 Surf Week Tour

Artigianato ecosostenibile con MAIA Shapes MAIA shapes ha partecipato all'Expo che si è tenuto giovedì 21 luglio a La Fabbrica della Puglia. Le tavole ecosostenibili di questo marchio italiano hanno sfilato all'evento del Surf Week Tour insieme a Flamingo Surf Club.   Tavole artigianali che rispettano l'ambiente Oltre a essere dei surfisti professionisti, Alessandro e […]

Link
février 9, 2024 February events | What's next

Scopri gli eventi BLS di questo mese

24-27 ottobre
A+A 2023
Düsseldorf, Germania
stand n. 9B32

Link

Abonnez-vous à la newsletter

Recevez des mises à jour sur nos événements, actualités, catalogue et initiatives à venir.
Souscrire

Nous contacter

Écrivez-nous pour tous vos besoins, nous vous répondrons dans les 48 heures.
Informations requises

BLS S.R.L.
Società a Socio Unico
via dei Giovi, 41 - 20032 Cormano (MI) - Italia
t/f +39 02 39310212 / 66200473
info@blsgroup.it
Privacy Policy - Cookie Policy

Bureau d'inscription
via dei Giovi, 41 – 20032 Cormano (MI) - Italia
Capitale Sociale | Share Capital: Euro 600.000,00 i.v.
C.C.I.A.A. - R.E.A.: MI 1186898
Partita IVA | VAT N°: IT12296780153
C.F. e Iscrizione al Registro delle Imprese di Milano: 07822320151

BLS IBERIA / Av. Pau Casals, 8 08182 Sant Feliu de Codines Barcelona - Spain
BLS NORTHWEST / Reeweg, 132 3343 AP H.I. Ambacht Rotterdam - The Netherlands
BLS DO BRASIL / Rua Alvarenga Peixoto, 307 05095-010 Sao Paulo - SP - Brazil
BLS GERMANY / Steindeich 1a, 25377 Kollmar - Germany
BLS FRANCE / 18 Porte du Grand Lyon 01700 Neyron - France

crossmenuchevron-downcross-circle
FR